Paediatric diabetes: achieving practical, effective insulin therapy in type 1 and type 2 diabetes (Q36971945)

17 August 2017

1 reference

title

Paediatric diabetes: achieving practical, effective insulin therapy in type 1 and type 2 diabetes (English)

1 reference

17 August 2017

0 references

1 reference

1 reference

type 2 diabetes

9 December 2023

T Danne

1

1 reference

17 August 2017

D Becker

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

17 August 2017

1 reference

17 August 2017

96

1 reference

17 August 2017

11

1 reference

17 August 2017

1560-1570

1 reference

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Changing Prevalence of Overweight Children and Adolescents at Onset of Insulin-Treated Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Type 2 diabetes in the young: the evolving epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Type 2 diabetes mellitus in European children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Postprandial plasma glucose: a good index of glycemic control in type 2 diabetic patients having near-normal fasting glucose levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

How do we educate young people to balance carbohydrate intake with adjustments of insulin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Type 2 diabetes mellitus in youth: the complete picture to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Early intensive insulin treatment for induction of long-term glycaemic control in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Insulin lispro versus regular insulin in children with type 1 diabetes on twice daily insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Effectiveness of postprandial Humalog in toddlers with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Variability of insulin absorption and insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Insulin Detemir Is Characterized by a Consistent Pharmacokinetic Profile Across Age-Groups in Children, Adolescents, and Adults With Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

The effect of hypoglycemic seizures on cognitive function in children with diabetes: a 7-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Glycaemic control with modified intensive insulin injections (MII) using insulin pens and premixed insulin in children with type-1 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Current practice of insulin pump therapy in children and adolescents - the Hannover recipe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Reducing injection pain in children and adolescents with diabetes: a review of indwelling catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Increasing the adherence of diabetic adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Reducing Acute Adverse Outcomes in Youths With Type 1 Diabetes: A Randomized, Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Diabetic angiopathy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Obesity, increased linear growth, and risk of type 1 diabetes in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00494.X

Diurnal glucose--dependent fluctuations in glycosylated hemoglobin levels in insulin-dependent diabetes

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1016/0026-0495(82)90140-8

Identifiers

DOI

10.1111/J.1651-2227.2007.00494.X

1 reference

release_q4mlsfb5trfslkufxplvuq2rku

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q4mlsfb5trfslkufxplvuq2rku

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference